Carregant...
Alterations of chemotherapeutic pharmacokinetic profiles by drug–drug interactions
BACKGROUND: Drug interactions in oncology are common place and largely ignored as we tolerate high thresholds of ‘toxic’ drug responses in these patients. However, in the era of ‘targeted’ or seemingly ‘less toxic’ therapy, these interactions are more commonly flagged and contribute significantly to...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3533254/ https://ncbi.nlm.nih.gov/pubmed/19239394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425250902753212 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|